SCHEMBL5649796

SCHEMBL5649796

O=C(NN1CCC(NCc2ccc3c(c2)OCCO3)C1)OCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
TSHR P16473 3/20 0.44
RAB9A P51151 2/20 0.44
NPC1 O15118 1/20 0.44
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM1A O60341 2/20 0.43
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
CTSL P07711 1/20 0.42
CTSB P07858 1/20 0.42
CTSK P43235 1/20 0.42
SIGMAR1 Q99720 2/20 0.42
ACHE P22303 2/20 0.41
BCHE P06276 1/20 0.41
BACE1 P56817 1/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13145833 0.85 SMN1; SMN2 (0.47) ALDH1A1TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL5650842 0.83 NPY5R (0.45) ALDH1A1TSHRRAB9ANPC1TP53
SCHEMBL3691553 0.76 KDM1A (0.45) ALDH1A1TSHRRAB9ANPC1KDM1A
SCHEMBL5649594 0.75 KDM4E (0.48) ALDH1A1TSHRMAPTKDM1AMAOA
SCHEMBL9381194 0.74 CTSL (0.53) ALDH1A1TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL13145817 0.71 ALDH1A1 (0.47) ALDH1A1TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL20492711 0.71 CYP2D6 (0.67) TSHRSIGMAR1ACHEBCHEBACE1
SCHEMBL11999842 0.71 LTA4H (0.52) ALDH1A1TSHRMAPTSMN1; SMN2KDM1A
SCHEMBL28743107 0.70 CTSL (0.48) ALDH1A1TSHRRAB9ANPC1SMN1; SMN2
SCHEMBL17140257 0.70 KEAP1 (0.51) ALDH1A1RAB9ANPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7223776-B2 Compounds with anti-bacterial activity MORPHOCHEM AG (DE) 2007-05-29 US disclosed
US-20060040949-A1 Novel compounds with antibacterial activity MORPHOCHEM AG 2006-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040949-A1 Novel compounds with antibacterial activity MRPL21, Q6ZSR9, MRPL19 ALDH1A1 2434/4885TSHR 4639/4885RAB9A 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.